Name: GERON CORP (GERN) Stock
Brand: GERON CORP
Rating: 3.5 (3 reviews)

GERN Latest News, Press Relases and Analysis

All

Press Releases

19 days ago - By: Chartmill

Geron Corp (NASDAQ:GERN) Reports Mixed Q3 2025 Results, Misses Revenue Estimates

19 days ago - By: Zacks Investment Research - Mentions: IMTX

Geron (GERN) Reports Q3 Loss, Lags Revenue Estimates

19 days ago - By: Geron Corporation

Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights

19 days ago - By: Benzinga - Mentions: TECH INSE GEF SKYT ...

Earnings Scheduled For November 5, 2025

20 days ago - By: Benzinga

Geron Earnings Preview

20 days ago - By: Geron Corporation

Geron Corporation to Present at Upcoming Investor Conferences

21 days ago - By: Geron Corporation

Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies

25 days ago - By: Zacks Investment Research - Mentions: ACLX

Arcellx, Inc. (ACLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

26 days ago - By: Zacks Investment Research - Mentions: RARE

Geron (GERN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

a month ago - By: Geron Corporation

Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025

a month ago - By: Bragar Eagel & Squire

GERON (GERN) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

a month ago - By: Geron Corporation

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Geron Corporation

Geron Corporation Announces Executive Leadership Transitions and Appointments

2 months ago - By: Geron Corporation

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Geron Corporation

Geron to Participate in the 2025 Wells Fargo Healthcare Conference

3 months ago - By: Geron Corporation

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Bragar Eagel & Squire

GERON (GERN) ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

4 months ago - By: Geron Corporation

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: The Motley Fool

Geron (GERN) Q2 Revenue Jumps 5,477%

4 months ago - By: Zacks Investment Research - Mentions: TELA

Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates

4 months ago - By: Geron Corporation

Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights

4 months ago - By: Geron Corporation

Geron Appoints Harout Semerjian as President and Chief Executive Officer

4 months ago - By: Geron Corporation

Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025

4 months ago - By: Geron Corporation

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Geron Corporation

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Geron Corporation

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program

6 months ago - By: Geron Corporation

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Bragar Eagel & Squire

GERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

6 months ago - By: Yahoo Finance - Mentions: DHI CMG

Why Geron Corporation (GERN) Is The Best Low Priced Biotech Stock to Buy Now

7 months ago - By: Faruqi & Faruqi, LLP

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

7 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers - GERN

7 months ago - By: The Gross Law Firm

The Gross Law Firm Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN

7 months ago - By: Faruqi & Faruqi LLP

Faruqi & Faruqi Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN

7 months ago - By: THE ROSEN LAW FIRM, P. A.

GERN Deadline: GERN Investors with Losses in Excess of $100K Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit

7 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers – GERN

7 months ago - By: Levi & Korsinsky, LLP

GERON CORP (GERN) Stock News

GERN Latest News, Press Relases and Analysis

Geron Corp (NASDAQ:GERN) Reports Mixed Q3 2025 Results, Misses Revenue Estimates

Geron (GERN) Reports Q3 Loss, Lags Revenue Estimates

Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Earnings Scheduled For November 5, 2025

Geron Earnings Preview

Geron Corporation to Present at Upcoming Investor Conferences

Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies

Arcellx, Inc. (ACLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Geron (GERN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025

GERON (GERN) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation Announces Executive Leadership Transitions and Appointments

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron to Participate in the 2025 Wells Fargo Healthcare Conference

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GERON (GERN) ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Geron (GERN) Q2 Revenue Jumps 5,477%

Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates

Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Geron Appoints Harout Semerjian as President and Chief Executive Officer

Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Why Geron Corporation (GERN) Is The Best Low Priced Biotech Stock to Buy Now

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers - GERN

The Gross Law Firm Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN

Faruqi & Faruqi Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN

GERN Deadline: GERN Investors with Losses in Excess of $100K Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers – GERN

Contact Levi & Korsinsky by May 12, 2025 Deadline to Join Class Action Against Geron Corporation(GERN)